Your browser doesn't support javascript.
loading
Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer.
Blagden, Sarah P; Hamilton, Anne L; Mileshkin, Linda; Wong, Shirley; Michael, Agnieszka; Hall, Marcia; Goh, Jeffrey C; Lisyanskaya, Alla S; DeSilvio, Michelle; Frangou, Eleni; Stronach, Euan A; Gopalakrishna, Prashanth; Meniawy, Tarek M; Gabra, Hani.
Afiliação
  • Blagden SP; Ovarian Cancer Action Research Centre, Imperial College London, United Kingdom. sarah.blagden@oncology.ox.ac.uk.
  • Hamilton AL; Department of Oncology, University of Oxford, United Kingdom.
  • Mileshkin L; Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Wong S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Michael A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Hall M; Western Hospital, Melbourne, Victoria, Australia.
  • Goh JC; University of Surrey, Guildford, United Kingdom.
  • Lisyanskaya AS; Mount Vernon Cancer Centre, Middlesex, United Kingdom.
  • DeSilvio M; Royal Brisbane & Women's Hospital, Queensland, Australia.
  • Frangou E; University of Queensland, Saint Lucia, Queensland, Australia.
  • Stronach EA; St Petersburg City Oncology Hospital, St Petersburg, Russia.
  • Gopalakrishna P; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Meniawy TM; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
  • Gabra H; Ovarian Cancer Action Research Centre, Imperial College London, United Kingdom.
Clin Cancer Res ; 25(5): 1472-1478, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30563934

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido